255 related articles for article (PubMed ID: 15966241)
21. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
24. Two cases of gastrointestinal stromal tumor of the stomach with lymph node metastasis.
Sato T; Kanda T; Nishikura K; Hirota S; Hashimoto K; Nahagawa S; Ohashi M; Hatakeyama K
Hepatogastroenterology; 2007 Jun; 54(76):1057-60. PubMed ID: 17629038
[TBL] [Abstract][Full Text] [Related]
25. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
[TBL] [Abstract][Full Text] [Related]
26. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal stromal tumor in Brazil: clinicopathology, immunohistochemistry, and molecular genetics of 513 cases.
Lopes LF; Ojopi EB; Bacchi CE
Pathol Int; 2008 Jun; 58(6):344-52. PubMed ID: 18477213
[TBL] [Abstract][Full Text] [Related]
28. High incidence of microscopic gastrointestinal stromal tumors in the stomach.
Kawanowa K; Sakuma Y; Sakurai S; Hishima T; Iwasaki Y; Saito K; Hosoya Y; Nakajima T; Funata N
Hum Pathol; 2006 Dec; 37(12):1527-35. PubMed ID: 16996566
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Ryu MH; Kang YK; Jang SJ; Kim TW; Lee H; Kim JS; Park YH; Lee SS; Ryoo BY; Chang HM; Lee JL; Yook JH; Kim BS; Lee JS
Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479
[TBL] [Abstract][Full Text] [Related]
31. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
32. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
33. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
34. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours.
Pang NK; Chin SY; Nga ME; Chang AR; Ismail TM; Omar SS; Charlton A; Salto-Tellez M
Cytopathology; 2009 Oct; 20(5):297-303. PubMed ID: 19207305
[TBL] [Abstract][Full Text] [Related]
35. Histopathological features and clinical course of the gastrointestinal stromal tumors.
Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
[TBL] [Abstract][Full Text] [Related]
36. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
37. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
38. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
39. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
[TBL] [Abstract][Full Text] [Related]
40. Keratin-positive gastrointestinal stromal tumor of the stomach mimicking gastric carcinoma: diagnosis confirmed by c-kit mutation analysis.
Lippai N; Füle T; Németh T; Benedek G; Mályi I; Pádi E; Sápi Z
Diagn Mol Pathol; 2008 Dec; 17(4):241-4. PubMed ID: 18382354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
